glp-1 leaky gut Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential A sympathetic brake on gut

In September 2025, the FDA reported instances of compounded GLP-1 products containing unapproved foreign substances and companies selling drugs to consumers that were falsely labeled for research purposes. A 2024 report also found that many active pharmaceutical ingredients for compounded GLP-1s were imported from unregistered foreign suppliers, raising questions about supply chain oversight

[DOI] [PubMed] [Google Scholar] 7.Lee Y.H., Lee H.W., Choi H.J

Mattison McGee Lost over 60 lbs *Personal results may vary based on our individualized health programs

While we dont prescribe these medications, we can: Perform regular neuropathy assessments (e.g., monofilament testing, vibration perception) to track changes in sensation over time

This technology underpins the formulation of oral semaglutide (Rybelsus) and enables its effective absorption in the stomach, as illustrated in Fig